FDA experts weigh authorizing Novavax COVID-19 vaccine in US

A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy. Three vaccines are currently approved in the United States: Pfizer and Moderna, which are based on messenger RNA, and Johnson and […]
Continue reading »